Sanofi (SNY) Cash from Operations (2009 - 2026)

Sanofi has disclosed Cash from Operations across 8 years of filings, most recently posting $3.4 billion for Q2 2026.

• In Q2 2026, Cash from Operations rose 107.9% year-over-year to $3.4 billion; the TTM figure through Jun 2026 stood at $17.2 billion (up 40.07% YoY), while the FY2025 annual figure was $12.5 billion, up 27.32% from the prior year.
• Cash from Operations came in at $3.4 billion for Q2 2026 at Sanofi, up from $2.0 billion in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of $9.0 billion in Q4 2022 to a low of $95.6 million in Q1 2024.
• Average Cash from Operations over 5 years is $3.3 billion, with a median of $2.2 billion recorded in 2025.
• Year-over-year, Cash from Operations sank 96.76% in 2024 and soared 2202.93% in 2025.
• Over 5 years, Cash from Operations stood at $9.0 billion in 2022, then plunged by 80.71% to $1.7 billion in 2023, then sank by 81.85% to $315.2 million in 2024, then soared by 921.75% to $3.2 billion in 2025, then rose by 6.82% to $3.4 billion in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were $3.4 billion in Q2 2026, $2.0 billion in Q1 2026, and $3.2 billion in Q4 2025.